• Home
  • Technology
  • Gaming
  • Entertainment
  • World & Business
  • Science
  • Sports
  • AI
HomeTechnologyGamingEntertainmentWorld & BusinessScienceSportsAI
    • HomeTechnologyGamingEntertainmentWorld & BusinessScienceSportsAI
    • Home
    • Technology
    • Gaming
    • Entertainment
    • World & Business
    • Science
    • Sports
    • AI
    AI

    NewLimit CEO Says AI Matches Recombinant DNA Scale in Biotech

    Quote from NewLimit CEO shared in post of techno-optimist clips.

    TT
    1 Source, 29d ago, first seen 29d ago

    TLDR

    A tweet from @technooptimist1 quoted Jacob Kimmel, CEO of NewLimit, stating that artificial intelligence in biopharma is the first revolution of the same scale as recombinant DNA and the first technology disruption on the same order of magnitude. The post presented the remarks as part of daily clips featuring leading techno-optimists and ended mid-sentence on expected future developments. No additional confirmation or context appears in the packet.

    Combined views

    2.2K

    1 Source, first seen 29d ago

    Combined views

    2.2K

    1 Source, first seen 29d ago

    23 likes
    23 likes
    1 comments
    12 saves
    4 reposts

    Sentiment

    Positive——Negative

    Summary

    Not enough discussion yet.

    No sentiment analysis available yet.

    1 comments
    12 saves
    4 reposts

    Sentiment

    Positive——Negative

    Summary

    Not enough discussion yet.

    No sentiment analysis available yet.

    Today's Rank

    —

    Not ranked yet

    Today's Rank

    —

    Not ranked yet

    1 Source

    @technooptimist1.@newlimit CEO @jacobkimmel on why AI is biotech's biggest shift in 40+ years: "I really do think artificial intelligence in biopharma is the first revolution we've seen since recombinant DNA of the same scale. It's the first technology disruption on the same order of magnitude. And I think what we're going to see is some of these firms that are developing models that help us design molecules, partner with pharmas to develop those molecules and make medicines that just couldn't have existed before." — Jacob Kimmel, Co-Founder and CEO of NewLimit, on @corememory

    1 Source

    @technooptimist1.@newlimit CEO @jacobkimmel on why AI is biotech's biggest shift in 40+ years: "I really do think artificial intelligence in biopharma is the first revolution we've seen since recombinant DNA of the same scale. It's the first technology disruption on the same order of magnitude. And I think what we're going to see is some of these firms that are developing models that help us design molecules, partner with pharmas to develop those molecules and make medicines that just couldn't have existed before." — Jacob Kimmel, Co-Founder and CEO of NewLimit, on @corememory